By C. Sibur-Narad. Central Washington University.

Often mothers bring their children at less frequent intervals than those suggested here purchase 160mg tricor with mastercard. If the child is first seen at a later stage than indicated in the immunization scheme discount 160mg tricor mastercard, the immunization is started with vaccines 1 buy discount tricor 160mg,2,3 and 4, given with four weeks interval. Reusable needles and syringes should be sterilized correctly (steam sterilization or boiling for 20 minutes) 2. What are the dangers of using contaminated syringes and needles during vaccination and what are the steps to be used to prevent it? The vaccine preventable diseases estimated to account for one third of infant and child disability and mortality in Ethiopia. Mental Retardation: If a child is significantly retarded in his psychomotor development (milestones) we suspect subnormal intelligence and speak of mental retardation. In very mild case there may be only minimal brain damage giving rise to slight delay only and less than optimal intelligence may only become obvious in school. He can not sit without support at age 9 months, can not stand at at age 15 months, can not walk at age 18 months b. He can not lough loudly at age 6 months, speak three words at age 2 years, and follow a few simple directions at age 3 years c. He can not grasp actively at age 6 months, and take small objects with thumb and finger at age 1 year. Inherited abnormalities or subnormalities of the brain like in microcephalus, hydrocephalus. An abnormality of chromosomes the carrier of inheritance in the cellular nucleus the feature of mongolism (Down’s syndrome) characteristic faces with slanting eyes, a small flat nose a protruding tongue, low set ears and small head. Perinatal problems (prematurity, asphyxia) , or disease acquired after the neonatal period (meningitis, encephalitis, cerebral malaria) may damage the brain d. Deafness can mimic mental retardation 182 Pediatric Nursing and child health care Management: Since there is no treatment of the cause 1. In moderate retardation habit training – eating, walking, and putting on cloths 2. In mild retardation special attention in schools or ideally special school can of value 3. It is a term used for all permanent, no-progressive, generalized brain damage in children irrespective of the cause. Usually some degree of spasticity symptoms are combined with mental retardation, but sometimes the mental retardation is minimal or even abscent. Prenatal: acquired disease such as congenital infection Perinatal: (shortly before or after delivery) : asphyxia, cerebral hemorrhage, b. After the first week of life: meningitis, encephalitis, cerebral malaria can also cause cerebral palsy 183 Pediatric Nursing and child health care Clinical Features: 1. Spastic paralysis if the lesion unilateral or spastic paraplegia if the lesion bilateral 2. Regular exercise under the guidance of physiotherapist help in preventing deformity and contracture 2. Parents of such children support and reassurance Prevention: • Proper antenatal and perinatal care, • early recognition of meningitis etc 13. Down’s Syndrome: Down’s syndrome is a chromosomal abnormality involving an extra chromosome (number 21) characterized by a typical physical appearance and mental handicap. Abnormal attachment of chrosomes inherited from parents 184 Pediatric Nursing and child health care Clinical Manifestations: 1. If diagnosed within the first month of life and substitution with thyroid hormone continued regularly the child will have a normal life 3. With late diagnosis and inadequate treatment the child will be severely retarded and handicapped 13. Polyuria, and polydipsia in young children are symptoms to make you think of diabetes mellitus which is not uncommon and is often overlooked Findings of sugar in urine, and an increased blood sugar prove the diagnosis. Addele Pilliteri (1987), Child health Nursing, care of the growing child, Little, Brown and Company. Addele Pilliteri (1992), Maternal and child health Nursing, care of the child bearing and child rearing family, J. A Tiu (1991), Essential Paediatric Nursing, Chelmstord, Kampala 189 Pediatric Nursing and child health care 12. Katharyn May, Laura Mahlmeister (1990), Comprehensive Maternity Nursing, nursing Process and the child bearing family, J. Maurice King, Felicity king (1978), Primary Child Care, a manual for health workers, Oxford University Press.

The Eastern Mediterranean and South-East Asia regions show moderate proportions of resistance discount tricor 160 mg fast delivery, followed by the Western Pacific region 160mg tricor. Eastern Europe continues to report the highest proportions of resistance globally and for all first-line drugs buy cheap tricor 160 mg on line. There are important variations within regions, particularly in the Eastern Mediterranean and the Western Pacific regions, and in Europe if Central, Eastern and Western Europe are grouped together (although Central and Western Europe show little variation in resistance across the region). In the Republic of Korea, the slowing in the decline of the notification rate has been attributed to an expanding surveillance system that reaches the private sector. A better programme can reduce the overall number of cases, particularly re-treated cases; however, difficult (resistant) cases may persist. Improvement in laboratory proficiency, particularly the sensitivity and specificity of drug-susceptibility testing, may also affect the observed prevalence of resistance. The scenarios outlined above highlight the importance of evaluating trends in prevalence of drug resistance within the context of relevant programme developments. One limitation is the insufficient quality assurance of drug-susceptibility testing for second-line drugs. Another limitation is that second-line drug-susceptibility testing is not available in most countries. The cost of shipping of isolates and the cost of second-line testing is significant. Myanmar is surveying risk populations, but is currently showing low proportions of second-line drug resistance. Quinolones are widely available in this region; therefore, determining the extent of resistance to this class of drug is a priority, as is establishing cross-resistance between early and later generations of quinolones. Second-line drugs are locally available in most of the countries of the former Soviet Union and have been widely used for a long time. Both of these factors, smear negativity and shorter duration of disease due to mortality, may suggest a lower rate of general transmission. Additional information on risk factors, including history of hospitalization or imprisonment, was not available for this analysis, so the specific reasons for the association are not known. Better surveillance data may help in developing an understanding of the relationship between these epidemics; however, additional studies should be undertaken in several settings to answer the questions that surveys cannot. China and India are estimated to carry 50% of the global burden, with the Russian Federation carrying a further 7%. Prevalence can be estimated by multiplying incidence by the average duration of the disease. In general, duration is expected to be longer because most patients will receive some treatment that will contribute to prolongation of disease rather than curing it. The network has completed 13 rounds of proficiency testing since 1994; and cumulative results indicate an overall high performance. Although overall performance of the network is good, annually, one or two laboratories within the network will show suboptimal performance. This indicates the difficulty of executing high-quality drug-susceptibility testing year after year, and also highlights the importance of internal quality assurance. Results are determined judicially, and through the course of 13 rounds of proficiency testing, “borderline” strains have been encountered, where up to half the network has found these strains to be susceptible and the other laboratories have found them to be resistant. Since round 9, thorough pretesting has been used to exclude such strains from panels, but has not always been successful. Therefore, strains with less than 80% concordance within the network have been excluded from overall performance measures, so that judicial results are not distorted. Over a five-year period, 40 of 600 strains, or approximately 7% of strains included in annual panels, have been excluded. The study on borderline strains has been useful in confirming that the most important factor explaining the variation of the results of panel testing is strain selection. Currently, there is no established gold standard to replace the judicial 80 system. One possible solution would be a definition of “intermediary” resistant results; however, this would require testing at two concentrations. Many high- income countries will test drugs (at least isoniazid) at two concentrations. To date, no study has systematically evaluated all available methods for testing, established critical concentrations for all available second-line drugs, or evaluated a large number of clinical isolates for microbiological and clinical end-points. In July 2007, guidance was developed for the selection of and testing for second-line drugs. Based on evidence or expert consensus (where no evidence was available), a hierarchy was developed recommending drug-susceptibility testing based on both clinical relevance and reliability of the test available. Rifampicin and isoniazid were prioritized, followed by ethambutol, streptomycin and pyrazinamide, and then the second-line injectables (amikacin, kanamycin and capreomycin) and fluroquinolones.